Navigation

ephedrine (pulmonary) (Primatene)

 

Classes: Alpha/Beta Agonists

Dosing and uses of Primatene (ephedrine (pulmonary))

 

Adult dosage forms and strengths

injectable solution

  • 50mg/mL

capsule

  • 25mg

 

Bronchospasm

25-50 mg SC/IM, Or

5-25 mg slow IV

12.5-25 mg PO q4hr PRN (not to exceed 150 mg/day)

 

Pediatric dosage forms and strengths

injectable solution

  • 50mg/mL

capsule

  • 25mg

 

Bronchospasm

>12 years old: 12.5-25 mg PO q4hr PRN (no more than 150 mg/day)

0.5 mg/kg SC/IM Or

16.7 mg/m² SC/IM q4-6hr

Potential toxic dose <6 years: 2 mg/kg

 

Primatene (ephedrine (pulmonary)) adverse (side) effects

Frequency not defined

Anxiety

Insomnia

Nervousness

Palpitations

Tachycardia

Vertigo

Difficult and painful urination (vesical sphincter spasm)

Precordial pain and cardiac arrhythmias may occur from ephedrine sulfate injection

 

Warnings

Contraindications

Hypersensitivity to ephedrine or other sympathomimetic agents

Angle-closure glaucoma

Concurrent use of other sympathomimetic agents

 

Pregnancy and lactation

Pregnancy category: C

Lactation: Likely excreted in breast milk

 

Pregnancy categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

 

Pharmacology of Primatene (ephedrine (pulmonary))

Mechanism of action

Alpha, beta-1, & beta-2 receptor agonist

 

Pharmacokinetics

Onset: 10-20 min (SC/IM);15-60 min (PO)

Half-Life: 4.85-6.47

Duration: <1 hr (SC/IM); 3-5hr (PO)

Peak Plasma: PO: 20-80 ng/mL

Vd: 220-240 L

Metabolism: liver

Metabolites: p-hydroxyephedrine, p-hydroxynorephedrine, norephedrine, and their conjugates

Clearance: 25.5-34.1 L/hr

Excretion: urine